To hear about similar clinical trials, please enter your email below
Trial Title:
Evaluation of Role of Intraoperative Ultrasound in Gross Total Resection of Gliomas
NCT ID:
NCT05707728
Condition:
Glioma
Conditions: Official terms:
Glioma
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Device
Intervention name:
intraoperative ultrasound
Description:
intraoperative cranial ultrasound
Arm group label:
totally resection of glioma using intraoperative ultrasound
Summary:
The use of intraoperative ultrasound (IOUS )seems to have significantly increased the
Gross total Resection rate achieved in brain gliomas surgery. As regard intraoperative
visualisation of the tumor and its residuals, the effectiveness of IOUS has been
documented in a series of 192 High Grade glioma patients, in which the combination of
neuronavigation and IOUS was also related to increased overall survival in a prospective
study of 32 patients, documented a good level of agreement between intraoperative
ultrasonography and postoperative contrast-enhanced MRI in detecting tumor residuel they
concluded that the IOUS produces results similar to those of MRI, and therefore, can be
used to maximize tumor resection.
Detailed description:
The use of intraoperative ultrasound (IOUS) during neurosurgical procedures was first
described in 1978 by MH Reid The initial interest towards US as an imaging tool in
neurosurgery progressively weaned from the 80's until the early 2000's in favor of other
imaging techniques such as CT and MRI
Maximal safe resection represents the gold standard for surgery of malignant brain
tumors:
gross total resection of the tumor while preserving the surrounding functional brain
tissue is the main goal, since it is associated with longer survival and better patient
quality of life This is particularly true for gliomas, the most common primary malignant
brain tumors Concerning gross total resection, accurate localization and precise
delineation of the tumor margins are required in order to avoid devastating lesions on
nervous structures Ultrasound may provide an alternative tool to intraoperative magnetic
resonance imaging (MRI) for delineating tumor Tissues and improving the chances of gross
total resection The purpose of brain tumor removal is maximal resection while sparing
healthy tissues. The extent of resection is a key prognostic factor in survival time,
functional recovery, and tumor recurrence rates The optimal results of brain lesion
surgery may be achieved by maximal surgical resection without disturbance of neurological
functions Due to the imprecise correlation between preoperative images,intraoperative
anatomy, and also poor differentiation of some tumors from a normal tissue, better
delineation of normal from tumor tissue intraoperatively could improve clinical outcome
as increasing chance of total resection and decreasing normal tissue damage .
Intraoperative imaging technology increases the extent of tumor resection and patients'
outcome including survival time.
Intraoperative MRI are time-consuming and of high cost. Computed tomography (CT) usually
is not of choice as ionizing radiation and limited mass delineation. Several researches
have demonstrated that the image quality of ultrasound has improved enough to visualize
and guide tumor resection The most important disadvantage of neuronavigation is the
inconsistency with preoperative images from changes of the lesion and critical anatomic
structures associated with brain shift as intraoperative tumor resection or cerebrospinal
fluid drainage. This creates the need for updating the preoperative image with the
intraoperative image
The use of intraoperative ultrasound (IOUS )seems to have significantly increased the
Gross total Resection rate achieved in brain gliomas surgery. As regard intraoperative
visualisation of the tumor and its residuals, the effectiveness of IOUS has been
documented in a series of 192 High Grade glioma patients, in which the combination of
neuronavigation and IOUS was also related to increased overall survival in a prospective
study of 32 patients, documented a good level of agreement between intraoperative
ultrasonography and postoperative contrast-enhanced MRI in detecting tumor residuel they
concluded that the IOUS produces results similar to those of MRI, and therefore, can be
used to maximize tumor resection.
Criteria for eligibility:
Study pop:
Patients with all grades of gliomas confirmed by MRI any age and any sex
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- Patients with all grades of gliomas confirmed by MRI , MRI with contrast and MR
spectroscopy .
- Age of the patient: any age.
- Both sex
Exclusion Criteria:
- • Other tumours and space occupying lesion (sol) rather than gliomas confirmed by
histopathology and preoperative imaging
- Patients unfit for surgery
Gender:
All
Minimum age:
N/A
Maximum age:
N/A
Healthy volunteers:
No
Start date:
March 2023
Completion date:
October 2024
Lead sponsor:
Agency:
Assiut University
Agency class:
Other
Source:
Assiut University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05707728